Thus, exosomal circSHKBP1 participated in the progression of NSCLC via the miR-1294/PKM2 axis. circSHKBP1 may be potential biomarker for the diagnosis and treatment of NSCLC.
Exosomal circSHKBP1 participates in non-small cell lung cancer progression through PKM2-mediated glycolysis.